New clinical trials of vaccines and drugs have helped bolster Uganda's arsenal of weapons to fight against an Ebola outbreak first detected two months ago.
Nov 21, 2022
0
6
Rutgers scientists have developed a new approach to stopping viral infections: a so-called live-attenuated, replication-defective DNA virus vaccine that uses a compound known as centanamycin to generate an altered virus for ...
Nov 18, 2022
0
57
COVID-19 vaccines and drugs were developed at "warp speed" and now experts are concerned about the US Food and Drug Administration's (FDA) inadequate surveillance of clinical trial sites, reports an investigation published ...
Nov 16, 2022
0
84
A team of international scientists from Griffith University and the University of Alberta are about to start human clinical trials for a strep A vaccine they hope will induce long-lasting immunity against the deadly pathogen ...
Nov 10, 2022
0
2
As the pandemic continues, many countries are rolling out COVID booster vaccines. In the U.K., the autumn booster campaign is offering a fourth dose to those at higher risk from a COVID infection, including people with certain ...
Nov 8, 2022
0
6
Incidence of myocarditis, pericarditis or myopericarditis is two- to threefold higher after a second dose of the Moderna Spikevax COVID-19 vaccine when compared to the Pfizer BioNTech COVID-19 vaccine; however, overall cases ...
Nov 7, 2022
0
31
Uganda on Saturday extended a three-week lockdown on two districts at the center of an Ebola outbreak which has claimed over 50 lives, curbing travel and closing public places.
Nov 6, 2022
0
51
The European Union has approved a preventative treatment for the very common virus that causes the chest infection bronchiolitis in infants, the companies that developed the drug said Friday.
Nov 4, 2022
0
5
An experimental vaccine against breast cancer safely generated a strong immune response to a key tumor protein, researchers from the University of Washington School of Medicine in Seattle report in a paper published by the ...
Nov 3, 2022
0
2102
Children aged 8 years or younger should be considered a group at high risk for more severe monkeypox disease, reports The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric ...
Oct 28, 2022
0
11
